Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Bad Rothenfelde – page 32

897 clinical trials in Bad Rothenfelde, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Bad Rothenfelde at a glance
897
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

897 trials in Bad Rothenfelde

Open in trial search

Bipolar I disorder

Not yet recruiting

A study to evaluate the safety and effectiveness of azetukalner in patients with bipolar depression

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azetukalner
  • Sponsor:Xenon Pharmaceuticals Inc.

A study to evaluate the safety and effectiveness of ADX-038 in adults with geographic atrophy caused by age-related macular degeneration.

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ADX-038
  • Sponsor:Adarx Pharmaceuticals Inc.

Bipolar I disorder

Not yet recruiting

A study to evaluate the effectiveness and safety of azetukalner in patients experiencing depressive episodes associated with bipolar disorder.

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azetukalner
  • Sponsor:Xenon Pharmaceuticals Inc.

Fabry's disease

Not yet recruiting

A Study of Migalastat Safety and Effects in Children Aged 2 to 12 Years with Fabry Disease and Suitable Gene Changes

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Migalastat hydrochloride
  • Sponsor:Amicus Therapeutics Inc.

Testing continuous versus intermittent treatment with cetuximab, fluorouracil, folinic acid, and irinotecan in patients with newly diagnosed metastatic colorectal cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Myasthenia gravis

Not yet recruiting

Study of TOL2 safety and immune response in patients with generalized myasthenia gravis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Glucose
  • Sponsor:Bonsai Biotherapeutics AB

Type 2 diabetes mellitus

Not yet recruiting

Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Insulin degludec
  • Sponsor:Novo Nordisk A/S

Medulloblastoma

Not yet recruiting

Comparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Carboplatin
  • Sponsor:GPOH gGmbH

Long-term Safety and Effectiveness Evaluation of RGX-314 in Patients with Neovascular Age-related Macular Degeneration

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Surabgene lomparvovec
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Enterobacter infection

Not yet recruiting

Study on the Effectiveness of Intestifix, Colistin Sulfate, and Vancomycin for Patients with Infections from Multidrug-Resistant Enterobacteriaceae

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Colistin Sulfate
  • Sponsor:Goethe University Frankfurt

Diffuse large B-cell lymphoma+2

Not yet recruiting

Study of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:Universitaet Muenster

Study on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Bad Rothenfelde

What the registry says about research in the country

01 Cardiac Surgery Research

Innovative clinical trials focusing on managing perioperative bleeding during complex cardiac procedures. This research explores the effectiveness of fibrinogen concentrate in combination with standard care protocols.

  • Blood Management Studies
  • Cardiac Surgery Complications
  • Transfusion Medicine

These investigations aim to advance bleeding management strategies during cardiopulmonary bypass procedures, potentially reducing the need for blood transfusions in the critical 24-hour post-surgery period.

02 Cardiovascular Therapeutics

Current research evaluates novel hemostatic agents in cardiovascular surgery, comparing their efficacy against placebo in controlled clinical settings.

  • Blood Conservation
  • Surgical Hemostasis
  • Patient Safety

The studies focus on optimizing patient outcomes by developing improved protocols for managing surgical bleeding complications.

03 Transfusion Medicine

Groundbreaking research in blood product alternatives and their application in major cardiac surgeries. These trials evaluate modern approaches to reducing allogeneic transfusion requirements.

  • Blood Product Management
  • Transfusion Protocols
  • Clinical Outcomes

This research aims to establish more effective blood management strategies for complex cardiac surgical procedures.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.